Skip to main content

Table 5 Provider knowledge of first-line treatment and dosing regimens, by sector¹

From: Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

 

Benin

DRC

Madagascar

Nigeria

Uganda

Zambia

 

Public/Not-for-Profit

Private

Public/Not- for-Profit

Private

Public/Not- for-Profit

Private

Public/Not- for-Profit

Private

Public/Not- for-Profit

Private

Public/Not- for-Profit

Private

 

N=218

N=735

N=135

N=1, 242

N=575

N=2, 016

N=258

N=1, 839

N=563

N=699

N=178

N=283

Correctly state the recommended first-line treatment for uncomplicated malaria

73.0 a

17.7 b

76.4 a

42.4 b

71.7 a

12.4 b

43.7 a

25.5 b

92.8 a

59.8 b

92.7 a

59.3 b

Correctly state the dosing regimen of the first-line treatment for an adult

70.7 a

8.4 b

70.4 a

28.5 b

42.4 a

5.1 a

--2

--

86.6 a

53.2 a

92.7 a

48.2 b

Correctly state the dosing regimen of the first-line treatment for a two year old

70.2 a

7.8 b

69.6 a

28.4 b

68.8 a

8.5 b

--

--

89.5 a

49.3 b

92.7 a

47.3 b

  1. ¹ Statistical comparisons conducted across outlet types, within countries. Statistical difference is labelled with a superscript, a or b. Proportions with different letters in their superscripts differ significantly from one another within countries (p < 0.01 for all tests).
  2. 2 Information on Nigeria's dosing regimen for their first-line alternative ACT, ASAQ, was not collected.